Mission statement · Company scope
“Our mission is to be the leading player in the development and commercialization of p53-targeted cancer therapies.”
In use2022 – now1 sighting
First seenMar 2022Added
Last seenMar 2022Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Market leadership (primary)
- Leads with
- Rank
- Best for
- Climate & health
- Formula
- The [rank] [category] for [who]
- Tone
- Plain
- Length
- 17 words · reading grade 13.1
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.77
- Record
- st_2d0da961e38417c1
- Classification confidence
- 0.95
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2022-03-15 · sec_sentence · 10-K · accession 0001558370-22-003671
View filing ↗0 to compareCompare